"LM_ID"	"COMMON_NAME"	"SYSTEMATIC_NAME"	"FORMULA"	"MASS"	"CATEGORY"	"MAIN_CLASS"	"SUB_CLASS"	"CLASS_LEVEL4"	"SYNONYMS"	"INCHI_KEY"	"INCHI"	"SMILES"	"KEGG_ID"	"HMDBID"	"CHEBI_ID"	"ABBREVIATION"	"PUBCHEM_COMPOUND_ID"	"LIPIDBANK_ID"	"SWISSLIPIDS_ID"	"CAYMAN_ID"	"ALT_CATEGORIES"	"ALT_MAIN_CLASSES"	"ALT_SUB_CLASSES"	"ALT_CLASS_LEVEL4S"	"TAXONOMY"	"CITATION"
"LMSP0505AO03"	"type II B antigen(d18:1/20:0)"	"Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)"	"C90H161N3O42"	"1956.055479"	"Sphingolipids [SP]"	"Neutral glycosphingolipids [SP05]"	"Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]"	"-"	"-"	"SZWHUBVLCQWRQB-LFWPJGPBSA-N"	"InChI=1S/C90H161N3O42/c1-6-8-10-12-14-16-18-20-21-22-23-25-27-29-31-33-35-37-58(104)93-49(50(103)36-34-32-30-28-26-24-19-17-15-13-11-9-7-2)45-120-85-73(117)70(114)78(57(44-100)128-85)130-89-75(119)80(64(108)53(40-96)124-89)133-83-59(91-47(4)101)66(110)76(55(42-98)126-83)129-88-74(118)79(63(107)52(39-95)123-88)132-84-60(92-48(5)102)67(111)77(56(43-99)127-84)131-90-82(135-86-71(115)68(112)61(105)46(3)121-86)81(65(109)54(41-97)125-90)134-87-72(116)69(113)62(106)51(38-94)122-87/h34,36,46,49-57,59-90,94-100,103,105-119H,6-33,35,37-45H2,1-5H3,(H,91,101)(H,92,102)(H,93,104)/b36-34+/t46-,49+,50-,51-,52-,53-,54-,55-,56-,57-,59-,60-,61-,62+,63+,64+,65+,66-,67-,68-,69+,70-,71+,72-,73-,74-,75-,76-,77-,78-,79+,80+,81+,82-,83+,84+,85-,86-,87-,88+,89+,90+/m1/s1"	"[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@H]6O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H](O)[C@H]5NC(=O)C)[C@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC"	"-"	"-"	"-"	"Hex(5)-HexNAc(2)-Fuc-Cer 38:1;O2"	"44261086"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"